title: Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy.
authors.forename: D M
authors.initials: DM
authors.lastname: Layton
authors.forename: G J
authors.initials: GJ
authors.lastname: Mufti
authors.forename: J
authors.initials: J
authors.lastname: Lyons
authors.forename: J W
authors.initials: JW
authors.lastname: Janssen
authors.forename: C R
authors.initials: CR
authors.lastname: Bartram
mesh_terms: D003561:Cytarabine / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D011905:Genes, ras; D006801:Humans; D008875:Middle Aged; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000235:genetics*
chemical_list: D003561:Cytarabine